Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.

O'Connor, Paul W; Kremenchutzky, Marcelo

O'Connor, Paul W; Kremenchutzky, Marcelo.

Affiliation

O'Connor PW; 1Multiple Sclerosis Clinic,St. Michael's Hospital,University of Toronto,Toronto,Ontario,Canada.
Kremenchutzky M; 2London Health Sciences Centre,Western University,London,Ontario,Canada.

Can J Neurol Sci ; 42(6): 372-80, 2015 Nov.

Article in En | MEDLINE | ID: mdl-26503087

Subject(s)

Clinical Trials as Topic; Leukoencephalopathy, Progressive Multifocal/diagnosis; Leukoencephalopathy, Progressive Multifocal/drug therapy; Multiple Sclerosis/drug therapy; Natalizumab/therapeutic use; Animals; Diagnosis, Dual (Psychiatry); Humans; Multiple Sclerosis/diagnosis; Treatment Outcome

Key words

Clinical neurosciences; Multiple sclerosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Leukoencephalopathy, Progressive Multifocal / Natalizumab / Multiple Sclerosis Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Can J Neurol Sci Year: 2015 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google